Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$8.52 - $24.77 $2.13 Million - $6.19 Million
-250,000 Reduced 83.33%
50,000 $464,000
Q2 2021

Aug 16, 2021

BUY
$11.62 - $44.5 $3.49 Million - $13.4 Million
300,000 New
300,000 $3.4 Million

Others Institutions Holding NRXP

About NRX Pharmaceuticals, Inc.


  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $111M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Owl Creek Asset Management, L.P. Portfolio

Follow Owl Creek Asset Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Owl Creek Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Owl Creek Asset Management, L.P. with notifications on news.